Filter
3586
Filtered Results: 3586
Text search:
Diagnostic
Testing
of
Children
Featured
Recommendations
368
New Publications
1001
Language
Document type
No document type
2219
Studies & Reports
485
Guidelines
470
Manuals
136
Strategic & Response Plan
121
Training Material
50
Fact sheets
48
Situation Updates
39
Infographics
8
Resource Platforms
4
Brochures
2
Online Courses
2
App
1
Videos
1
Countries / Regions
India
214
Kenya
126
Global
120
South Africa
92
Nigeria
90
Tanzania
83
Malawi
81
Liberia
74
Ethiopia
74
Uganda
72
Western and Central Europe
71
Sierra Leone
70
Nepal
66
Zambia
65
Rwanda
57
Africa
56
Ghana
50
Namibia
39
Myanmar / Burma
39
Latin America and the Carribbean
39
Bangladesh
36
Zimbabwe
34
Ukraine
32
Lesotho
31
Eastern Europe
30
Cambodia
27
Asia
27
Congo, Democratic Republic of
26
Philippines
26
Syria
26
Russia
21
Senegal
20
South–East Asia Region
20
Mozambique
19
Indonesia
17
Botswana
16
South Sudan
15
Germany
15
Haiti
14
Eastern Europe and Central Asia
14
Eswatini/ Swaziland
13
Burkina Faso
12
Brazil
12
East and Southern Africa
12
West and Central Africa
12
Guinea
11
Pakistan
11
Albania
11
Middle East and North Africa
9
Cameroon
8
Georgia
7
USA
6
Somalia
6
Afghanistan
6
Lebanon
6
Colombia
6
Yemen
6
Venezuela
6
Tajikistan
6
Benin
5
Central African Republic
5
Western Pacific Region
5
Moldova
5
Vietnam
5
Iraq
4
Jordan
4
North Macedonia
4
Armenia
4
Turkey
3
Papua New Guinea
3
Sudan
3
Argentina
3
Peru
3
Burundi
3
Ecuador
3
Angola
3
Madagascar
3
Sri Lanka
3
Paraguay
3
Bhutan
3
Palestine
3
Laos
3
Timor Leste/ East Timor
3
Iran
3
Saudi Arabia
2
Chad
2
Gambia
2
China
2
Bolivia
2
Mexico
2
Chile
2
Poland
2
Bulgaria
2
Romania
2
North America
2
Turkmenistan
2
United Kingdom
2
Mali
1
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Togo
1
Egypt
1
Thailand
1
Dominican Republic
1
Serbia
1
Hungary
1
Honduras
1
Greece
1
Libya
1
Guatemala
1
North Korea
1
Djibouti
1
Southern Africa
1
Qatar
1
Estonia
1
Slovakia
1
France
1
Maldives
1
Tunisia
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
1473
Clinical Guidelines
379
Public Health
178
Women & Child Health
153
Capacity Building
69
Key Resources
58
Pharmacy & Technologies
37
Annual Report MEDBOX
1
Toolboxes
HIV
511
TB
376
COVID-19
243
Mental Health
163
Rapid Response
107
AMR
103
NTDs
98
Caregiver
72
Ebola
71
Disability
69
NCDs
63
Conflict
54
Refugee
48
Pharmacy
48
Zika
31
Planetary Health
31
Cholera
24
Polio
22
Global Health Education
19
Health Financing Toolbox
18
Natural Hazards
14
Specific Hazards
10
Social Ethics
2
South Sudan
1
Asthma is the most common non-communicable disease in children and remains one of the most common throughout the life course. The great majority of...
Prevention and Control of Cholera Uganda
recommended
Operational Guidelines for the national and district health workers & planners.
These new approaches include use of selective chemotherapy, Rapid Diagnostic Tests (RDTs), Zinc for treatment ... cholera in children and complementary use of OCV
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks ... a pox-like disease occurred in monkeys kept for research. The first human case was recorded in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries.
In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response.
As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa.
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) dr...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment cri...
The document "Diabetes in Children and Young People" by NICE (National Institute for Health and Care Excellence) provides quality standards for the diagnosis, management, and support ... diabetes in children and adolescents.
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status ... stockout of critical COVID-19 medicines, equipment and supplies on site and to identify areas that need further attention to enable the facility to respond effectively to the pandemic. The tool encompasses key components that are essential to managing COVID-19 in a hospital setting, including:
health workforce (numbers, absences, COVID-19 infections, staff vaccinated for COVID-19 health workforce management, training and support);
medicines and medical supplies for management of COVID-19;
IPC capacities (protocols, safety measures, guidelines) and the availability of personal protective equipment (PPE) for staff;
diagnostic testing, imaging and patient monitoring devices and supplies
medical equipment for management of COVID-19, including O2 administration;
COVID-19 vaccine readiness ;
beds and space capacity.
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns ...
Guidelines on Management of COVID-19 in Kenya
recommended
It has been over a year since Kenya identified the first case of COVID-19 in the country. The Government formed the National COVID-19 task force, which supported the country's response through multi-sectoral technical working groups on ..., case management, risk communication and community engagement among others. An earlier version of the COVID case management guideline was released in April 2020 and capacity building of health care workers on diagnosis and treatment of COVID-19 was quickly carried out, even as counties prepared themselves by setting up isolation centres and supplies
Integrated Management of Childhood Illness (IMCI) is an integrated approach to child health that focuses on the holistic well-being of the child. IMCI aims to reduce death, illness and disability, a...
Refugees and migrants face similar health threats from COVID-19 as their host populations. However, inadequate access to essential services and exclusion may makes early detection, testing, diagnosis...
Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection
recommended
Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV ..., care and treatment. These recommendations include decentralization, integration and task-sharing, in addition to the use of point-of-care (POC) HCV viral load assays and reflex viral load testing.
Malar J (2017) 16:174 DOI 10.1186/s12936-017-1808-x
Background: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatment for uncomplicated malaria in Benin. In 2016, a medicine outlet survey was implemented to investigate the availability, price, and market share ... anti-malarial treatment and malaria diagnostics. Results provide a timely and important benchmark to measure future interventions aimed at increasing access to quality malaria case management services.
This topic last updated: Apr 28, 2020.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of y...
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendatio...
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibili...
2nd edition. The 2018 Roadmap incorporates an additional critical population: adolescents. Despite making up 1 in 6 of the world’s people, adolescents have been largely overlooked as global momentum to address TB has grown. Spanning the ages ... 10–19 years, adolescents are both at risk of TB and represent an important population for TB control. They often present with infectious TB and frequently have multiple contacts in congregate settings, such as schools and other educational institutions. Nevertheless, few countries capture TB data in suitably age-disaggregated ways to allow full understanding of its impact in this group and even fewer provide the adolescent-friendly services our young people need to access diagnosis and care.
These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populations.
The World Health Organization (WHO) first released consolidated guidelines on HTS in 2015, in r...
Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% ... AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosis and linking to appropriate treatment are critical actions national programs must take to reduce the burden of disease.
WHO in 2022 introduced updated guidelines for diagnosing, preventing, and managing cryptococcal disease among adults, adolescents and children living with HIV. This policy brief provides a summary of the key recommendations, clinical considerations, and also stresses the importance of ensuring access to life-saving antifungals. There is an urgent need for countries to scale-up management for not just cryptococcal meningitis, but address cryptococcal disease in the context of a package of care for advanced HIV disease as recommended by WHO.
Accessed November 2017
